SourcesWeb search

Products 41 to 50 of 130

Disease-Resistent Cacao Plant by Innovative Genomics Institute
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/10/08 14:51 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding + University
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Research Institution
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Gene Editing + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:38 (3 years ago)
Date last modified: 2020/12/18 14:38 (3 years ago)
Known funding amount: N/A
Funding types: Private Funding + University
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Endocannabinoids for intestinal infection treatment by University of Texas Southwestern Medical Center
Biotech components: Molecule + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 years ago)
Date last modified: 2020/12/18 14:39 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Biotech components: Bacteria
Business models: N/A
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/04/01 10:01 (5 years ago)
Date last modified: 2019/04/01 10:01 (5 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Security
Market status: Under Development
Organization type(s): Government
Product categories: Threat detection
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Epidiolex by EPIDIOLEX
Biotech components: N/A
Business models: B2B
Country of production: N/A
Country of distribution: USA
Intended consumer: Commercial + Consumer
Date added: 2019/04/01 10:02 (5 years ago)
Date last modified: 2019/04/12 09:32 (5 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: On the market
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/09/28 16:45 (5 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:59 (4 years ago)
Date last modified: 2020/02/10 09:59 (4 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2019/05/15 15:45 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Open Release
Source: Web search
Trading symbol: BAS (ETR)
Value chain stage: Input
Gen 3 technical and medical fiber by Kraig Biocraft Laboratories
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: 1,200,000 USD
Funding types: Shareholder Investment + Government
Industry: Medical + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: Web search
Trading symbol: KBLB (OTCQB)
Value chain stage: Input
Gene-edited Produce by Pairwise Plants
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/10/08 14:49 (5 years ago)
Known funding amount: 125,000,000 USD
Funding types: Private Funding + Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product